Healthcare | December 22, 2025
Care ADHD opens its first Global Capability Centre in India
UK headquartered digital health scale-up strengthens global tech and innovation footprint in the country
UK headquartered digital health scale-up strengthens global tech and innovation footprint in the country
GSK will make most of its inhaled respiratory portfolio and other products available on a direct purchasing platform, offering savings of up to 66%
Emcure becomes the first Indian company to exclusively distribute and commercialise Poviztra, a second brand of Novo Nordisk’s Semaglutide injection for weight management
The additional production will raise the installed capacity by 400 million and available capacity by 240 million at the facility
Tablets will be manufactured at Granules' US-based facility located in Chantilly, Virginia
Additional investments planned to expand the site’s capacity and capabilities to support growing manufacturing programs
Under the agreement, AVT06 is licensed to enter the US market in the fourth quarter of 2026
USFDA determines Sun Pharma's Baska facility inspection classification as OAI
Company acquires People Tree Hospital Yeshwanthpur for Rs. 430 crore
Travoprost ophthalmic solution is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension
Subscribe To Our Newsletter & Stay Updated
